{"nct_id":"NCT05557838","title":"Study of Durvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With Unresectable Hepatocellular Carinoma","status":"RECRUITING","status_verified_date":"2025-02","start_date":"2023-02-22","start_date_type":"ACTUAL","primary_completion_date":"2025-03-31","primary_completion_date_type":"ESTIMATED","completion_date":"2025-03-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}